TCEAL7 has been identified to be frequently deregulated in tumors, and its decreased expression often correlates with malignant clinical process and poor prognosis in several kinds of cancers, such as ovarian cancer [4], gastric adenocarcinoma [6] and non-small cell lung cancer [7]. This evidence concerns the gene TCEAL7 and ovarian carcinoma.